These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 34578803)

  • 21. Most patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency develop pathological or subnormal retinal function.
    Fahnehjelm KT; Liu Y; Olsson D; Amrén U; Haglind CB; Holmström G; Halldin M; Andreasson S; Nordenström A
    Acta Paediatr; 2016 Dec; 105(12):1451-1460. PubMed ID: 27461099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensory neuronopathy as a major clinical feature of mitochondrial trifunctional protein deficiency in adults.
    Nadjar Y; Souvannanorath S; Maisonobe T; Brisset M; De Lonlay P; Schiff M; Viala K; Boutron A; Nicolas G; Laforêt P
    Rev Neurol (Paris); 2020 May; 176(5):380-386. PubMed ID: 32253025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases.
    Moorthie S; Cameron L; Sagoo GS; Bonham JR; Burton H
    J Inherit Metab Dis; 2014 Nov; 37(6):889-98. PubMed ID: 25022222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thermo-sensitive mitochondrial trifunctional protein deficiency presenting with episodic myopathy.
    Schwantje M; Ebberink MS; Doolaard M; Ruiter JPN; Fuchs SA; Darin N; Hedberg-Oldfors C; Régal L; Donker Kaat L; Huidekoper HH; Olpin S; Cole D; Moat SJ; Visser G; Ferdinandusse S
    J Inherit Metab Dis; 2022 Jul; 45(4):819-831. PubMed ID: 35403730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. When the usual symptoms become an unusual diagnosis: a case report of trifunctional protein complex.
    Anderson S; Brooks SS
    Neonatal Netw; 2013; 32(4):262-73. PubMed ID: 23835545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical course and cardiovascular outcomes in patients with the long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.
    Kwiatkowska J; Wierzba J; Karaszewska A; Kozlowski D; Sykut-Cegielska J; Stanko A
    Cardiol J; 2017; 24(1):101-104. PubMed ID: 28245050
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases.
    Bo R; Yamada K; Kobayashi H; Jamiyan P; Hasegawa Y; Taketani T; Fukuda S; Hata I; Niida Y; Shigematsu Y; Iijima K; Yamaguchi S
    J Hum Genet; 2017 Sep; 62(9):809-814. PubMed ID: 28515471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retained visual function in a subset of patients with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (LCHADD).
    Dulz S; Atiskova Y; Engel P; Wildner J; Tsiakas K; Santer R
    Ophthalmic Genet; 2021 Feb; 42(1):23-27. PubMed ID: 33107778
    [No Abstract]   [Full Text] [Related]  

  • 29. The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario.
    Kennedy S; Potter BK; Wilson K; Fisher L; Geraghty M; Milburn J; Chakraborty P
    BMC Pediatr; 2010 Nov; 10():82. PubMed ID: 21083904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The frequencies of very long-chain acyl-CoA dehydrogenase deficiency genetic variants in Japan have changed since the implementation of expanded newborn screening.
    Osawa Y; Kobayashi H; Tajima G; Hara K; Yamada K; Fukuda S; Hasegawa Y; Aisaki J; Yuasa M; Hata I; Okada S; Shigematsu Y; Sasai H; Fukao T; Takizawa T; Yamaguchi S; Taketani T
    Mol Genet Metab; 2022 May; 136(1):74-79. PubMed ID: 35400565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Child neurology: Recurrent rhabdomyolysis due to a fatty acid oxidation disorder.
    Terrone G; Ruoppolo M; Brunetti-Pierri N; Cozzolino C; Scolamiero E; Parenti G; Romano A; Andria G; Salvatore F; Frisso G
    Neurology; 2014 Jan; 82(1):e1-4. PubMed ID: 24379101
    [No Abstract]   [Full Text] [Related]  

  • 32. Tracer-based lipidomics enables the discovery of disease-specific candidate biomarkers in mitochondrial β-oxidation disorders.
    Schwantje M; Mosegaard S; Knottnerus SJG; van Klinken JB; Wanders RJ; van Lenthe H; Hermans J; IJlst L; Denis SW; Jaspers YRJ; Fuchs SA; Houtkooper RH; Ferdinandusse S; Vaz FM
    FASEB J; 2024 Feb; 38(4):e23478. PubMed ID: 38372965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and biochemical outcomes of patients with medium-chain acyl-CoA dehydrogenase deficiency.
    Anderson DR; Viau K; Botto LD; Pasquali M; Longo N
    Mol Genet Metab; 2020 Jan; 129(1):13-19. PubMed ID: 31836396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Newborn screening for medium chain acyl CoA dehydrogenase deficiency.
    Leonard JV; Dezateux C
    Arch Dis Child; 2009 Mar; 94(3):235-8. PubMed ID: 18838415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency and progressive retinopathy: one case report followed by ERGs, VEPs, EOG over a 17-year period.
    Rigaudière F; Delouvrier E; Le Gargasson JF; Milani P; Ogier de Baulny H; Schiff M
    Doc Ophthalmol; 2021 Jun; 142(3):371-380. PubMed ID: 33392894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mitochondrial trifunctional protein deficiency: an adult patient with similar progress to Charcot-Marie-Tooth disease].
    Yamamoto Y; Matsui N; Hiramatsu Y; Miyazaki Y; Nodera H; Izumi Y; Takashima H; Kaji R
    Rinsho Shinkeigaku; 2017 Feb; 57(2):82-87. PubMed ID: 28132977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinal Dystrophy in Long-Chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency.
    Androudi S; Mataftsi A; Brazitikos P
    Ophthalmol Retina; 2018 Jan; 2(1):74. PubMed ID: 31047310
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurological outcome in long-chain hydroxy fatty acid oxidation disorders.
    Mütze U; Ottenberger A; Gleich F; Maier EM; Lindner M; Husain RA; Palm K; Beblo S; Freisinger P; Santer R; Thimm E; Vom Dahl S; Weinhold N; Grohmann-Held K; Haase C; Hennermann JB; Hörbe-Blindt A; Kamrath C; Marquardt I; Marquardt T; Behne R; Haas D; Spiekerkoetter U; Hoffmann GF; Garbade SF; Grünert SC; Kölker S
    Ann Clin Transl Neurol; 2024 Apr; 11(4):883-898. PubMed ID: 38263760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.